INSM Q3 2023 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$31B

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$79M+16.7% YoY

Gross Profit

$62M78.9% margin

Operating Income

-$148M-186.8% margin

Net Income

-$159M-201.0% margin

EPS (Diluted)

$-1.11

QoQ Revenue Growth

+2.4%

Cash Flow

Operating Cash Flow

-$136M

Free Cash Flow

-$139M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$1.6B

Stockholders' Equity

-$289M

Cash & Equivalents

$487M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$79M	$68M	+16.7%
Gross Profit	$62M	$54M	+14.9%
Operating Income	-$148M	-$128M	-15.6%
Net Income	-$159M	-$131M	-21.2%

Geographic Segments

UNITED STATES

$59M75%

JAPAN

$16M20%

Europe And The Rest Of The World

$4M5%